BIONANOLAB

The objective of BioNanoLab is to develop risk management strategies for bio- and nano-enabled materials that are commonly used in medical applications in order to understand what makes bio- and nano-materials toxic and how to make them safe. Our overarching goal is to develop an integrated risk management framework to assist making progress towards inherently safer design of bio- and nano-materials while preserving their original features and functionality.

 Our research has an innovation potential for:

• The enhancement and standardization of nanomaterial dispersions and characterizations
• The development of predictive toxicity models
• The development of innovative bio- and nano-materials with modified characteristics that could eliminate safety risks
• The development of a risk management framework
• The development of an integrative database for nanotoxicity data

Our outcomes will directly support the ongoing innovation and commercialization of nano- and bio-enabled products, and promote their safe and sustainable advancement.